HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

R- 2- (3- N- (2- benzo(1,4)dioxanylmethyl)- amino- 1- propyl)- 3(2H)- pyridazinone hydrochloride

The combined alpha1- and postsynaptically selective alpha2-blocker GYKI-16084 significantly improved the AUA symptom scores and increased Q(max) in patients with BPH, without inducing any adverse reaction, orthostatic changes or erectile dysfunction
Also Known As:
GYKI-16084
Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Varga, Attila: 1 article (06/2006)
2. Walter, György: 1 article (06/2006)
3. Romics, Imre: 1 article (06/2006)
4. Horváth, Katalin: 1 article (06/2006)

Related Diseases

1. Erectile Dysfunction
2. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)